AzTrials
AzTrials

Kidney CalculiNCT05269108

Safety and Efficacy of Fluoroscopy-free Technique During Retrograde Intrarenal Surgery for Renal Stones

A study testing Fluoroscopy-free RIRS and Standard RIRS in people with Kidney Calculi and Radiation Exposure, run by Al-Azhar University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aiming to reduce radiation exposure to patients and physicians, the investigators conduct this study protocol to evaluate the possibility of performing retrograde intrarenal surgery (RIRS) under direct visualization without fluoroscopy. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Fluoroscopy-free RIRS and Standard RIRS
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
503 participants
Where
1 siteEgypt
Study dates
25 Feb 2022to 4 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Renal stone.
  • Stone size: ≥10 mm.

Who cannot join

  • Partial and complete staghorn stones.
  • Pregnant women.
  • Morbid obesity.
  • Uncorrectable coagulation disorders.
  • Active urinary tract infection (UTI).
  • Stone in a calyceal diverticulum.
  • Urinary tract obstruction distal to the stone.
  • Concomitant pathology that needs intervention in the same setting.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Department of Urology, Al-Azhar University hospitals

    Cairo

Other trials in Egypt

About this study

Official title: Safety and Efficacy of Fluoroscopy-free Technique During Retrograde Intrarenal Surgery for Renal Stones: A Prospective, Randomized, Non-inferiority Trial

Aiming to reduce radiation exposure to patients and physicians, the investigators conduct this study protocol to evaluate the possibility of performing retrograde intrarenal surgery (RIRS) under direct visualization without fluoroscopy. the investigators will prospectively evaluate the outcome of fluoroscopy-free RIRS for renal stones in comparison with the standard technique. The investigators expected that the fluoroscopy-free technique has high safety and efficacy even in complicated cases.

Read the detailed description

With improved flexible URS instrumentation and lithotripsy technology, retrograde intrarenal surgery (RIRS) became an alternative and excellent option for renal stones. Fluoroscopy imaging may be necessary during various steps of RIRS, such as insertion of a guidewire and stent, access sheath insertion, detection of stone location and size, and assessment of collecting system anatomy.

In an effort to decrease radiation exposure, several studies were conducted to evaluate the possibility of performing RIRS under direct visualization without fluoroscopy. Most studies concluded that fluoroscopy-free RIRS is a feasible, effective, and safe technique. The reported stone-free rate ranged from 83.8% to 95.7%. No major complications were observed.

Despite the reported high safety and efficacy of the fluoroscopy-free RIRS technique, most of the studies were retrospective and included only uncomplicated cases, and none of the studies address its results against control.

In the present study, the investigators will prospectively evaluate the efficacy and safety of fluoroscopy-free RIRS for renal stones in comparison with fluoroscopy-guided technique as standard control. The study will include all patients with renal stones amenable to RIRS. The investigators expected that the fluoroscopy-free technique can deal with large stones and complex situations with high safety and success rate. The study hypothesis is that "the fluoroscopy-free technique has efficacy and safety similar to the fluoroscopy-guided technique".

The investigators also aim to determine the patients and surgical characteristics impacting the need for fluoroscopy. The intra-operative fluoroscopy imaging is expected to be necessary during RIRS, especially in complicated cases. In the fluoroscopic-free group, the fluoroscopic equipment will be available in the operating room and will be used if needed.

Being tested
Fluoroscopy-free RIRS, Standard RIRS
Medical subject headings
Kidney Calculi

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fluoroscopy-free RIRSProcedure or surgery

    RIRS for renal stone under direct visualization, without fluoroscopy

  • Standard RIRSProcedure or surgery

    RIRS for renal stone under fluoroscopy-guidance

Study groups in NCT05269108
Study groupRoleWhat they receive
Fluoroscopy-free RIRSExperimentalPatients will be treated by RIRS without fluoroscopy
Receives: Procedure: Fluoroscopy-free RIRS
Standard RIRSActive comparatorStandard RIRS under fluoroscopy-guidance will be performed
Receives: Procedure: Standard RIRS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. stone-free rate

    defined as no residual stone or residual fragment(s) less than 4 mm (as confirmed by CT-UT).

    Measured: 3-months after the intervention.

  2. complication rate

    intraoperative and postoperative complications

    Measured: intraoperative till 3-months postoperative complications

Secondary outcomes (3)
  1. fluoroscopy time

    intraoperative fluoroscopy imaging

    Measured: intraoperative

  2. Operative time

    Time from induction of anesthesia till the end of the procedure

    Measured: The procedure time

  3. the need for fluoroscopy

    The need for fluoroscopy imaging in a fluoroscopy-free group

    Measured: Intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2022
  2. Study start25 Feb 2022
  3. Primary completion4 Feb 2024
  4. Study completion4 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The 1st group: Fluoroscopy-free RIRS. The 2nd group: Fluoroscopy-guided RIRS.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
503 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05269108
Sponsor's protocol ID
Uro_Azhar_2_022
Status last verified
Apr 2023
First submitted
25 Feb 2022
Last updated
14 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ahmed AF, ElShazly A, Daoud A, Abdelazim H, AlGammal M. Safety and Efficacy of Fluoroscopy-Free Technique During Retrograde Intrarenal Surgery for Renal Stones: A Prospective, Randomized, Controlled, Noninferiority Trial. J Endourol. 2025 Jul;39(7):636-645. doi: 10.1089/end.2025.0120. Epub 2025 May 14.

    PubMed 40364776

Questions about this trial

What is this clinical trial studying?

A study testing Fluoroscopy-free RIRS and Standard RIRS in people with Kidney Calculi and Radiation Exposure, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

stone-free rate (time frame: 3-months after the intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05269108, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in